TL;DR
This paper uses cryo-electron microscopy to reveal the structural basis for how the cholecystokinin A receptor (CCKAR) recognizes its ligand and interacts with different G proteins. This work provides a crucial framework for understanding CCKAR's promiscuous signaling and offers insights for developing new drugs targeting gastrointestinal and metabolic diseases.
What Problem Does This Paper Address?
The cholecystokinin A receptor (CCKAR) is a G protein-coupled receptor (GPCR) that plays a key role in regulating nutrient homeostasis and is a promising drug target for conditions like obesity and gastrointestinal disorders. A unique characteristic of CCKAR is its ability to bind to sulfated ligands and, more importantly, to interact with multiple types of G proteins (Gs, Gi, and Gq). This "promiscuity" in G protein coupling is unusual for GPCRs, where typically a specific receptor couples to a single G protein subtype. However, the structural mechanisms underlying both CCKAR's ligand recognition and its promiscuous G protein coupling remained largely unknown, hindering rational drug design.
Methods
The researchers employed cryo-electron microscopy (cryo-EM) to determine the high-resolution structures of the CCKAR in complex with three different G protein heterotrimers (Gq, Gs, and Gi) bound to its sulfated ligand, CCK-8. This technique allows for the visualization of these large molecular complexes. They also utilized mutagenesis studies and BRET (bioluminescence resonance energy transfer) assays to functionally validate the structural findings and probe the roles of specific residues and regions in ligand binding and G protein coupling.
Datasets
Not discussed in the paper.
Key Insights and Ideas
- CCKAR's "Active" Conformation: The structures reveal that CCKAR adopts a fully active conformation, similar to other activated GPCRs, with outward movements of transmembrane helix 6 (TM6).
- Ligand Recognition Mechanism: CCK-8 binds in an orthosteric pocket formed by transmembrane helices and extracellular loops. A key interaction for recognizing the sulfated form of CCK-8 involves the sulfate group of tyrosine interacting with Arginine 197 (R197) in the extracellular loop 2 (ECL2).
- G Protein Coupling Determinants: While the CCKAR structure is similar across different G protein complexes, subtle differences in the "wavy hook" region of the Gα subunit and the receptor's intracellular loop 3 (ICL3) are critical for determining coupling selectivity.
- "Wavy Hook" and ICL3 Roles: The "wavy hook" motif on the Gα subunit's α5 helix plays a crucial role in dictating G protein selectivity, with specific substitutions significantly impacting CCKAR's coupling to Gs. Similarly, the ICL3 loop of CCKAR forms specific hydrophobic interactions with the Gαq subunit, contributing to its preferential coupling.
- Structural Basis for Promiscuity: The study provides a detailed structural explanation for CCKAR's ability to couple with multiple G proteins, highlighting how variations in both the receptor and G protein interfaces contribute to this promiscuity.
Key Results
- Three cryo-EM structures of CCK-8 activated CCKAR complexed with Gq, Gs, and Gi heterotrimers were determined at resolutions of 2.9 Å, 3.1 Å, and 3.2 Å, respectively.
- Mutagenesis studies confirmed that R197 in ECL2 is a major determinant for discriminating between sulfated and non-sulfated CCK.
- BRET assays demonstrated that mutations in the "wavy hook" region of Gα subunits significantly affected CCKAR's coupling activity, particularly for Gs.
- A specific mutation (I296G) in CCKAR's ICL3 loop significantly weakened Gq coupling, highlighting its importance in this interaction.
- The study found that Gq coupling enhances the binding affinity of CCK-8 to CCKAR, suggesting an allosteric modulation effect.
Limitations and Future Work
The authors acknowledge that while they present structures with Gq, Gs, and Gi, they were unable to obtain a structure with the G12/13 subtype, which is also known to couple to CCKAR. Future work could focus on obtaining this structure to further elucidate the full spectrum of CCKAR's G protein coupling. The detailed structural insights also provide a strong foundation for designing novel small molecule agonists or antagonists that can selectively target specific CCKAR-G protein interactions, potentially leading to more precise therapeutic interventions.
Summary updated